Evolution of germline testing, mutation spectrum and clinico-pathological features in male breast cancer: a 27-year retrospective cohort including 69 patients.

Fiche publication

Date publication

juillet 2026

Journal

Cancer genetics

Auteurs

Membres identifiés du Cancéropôle Est :
Pr MATHELIN Carole , Dr CHRETIEN Manon

Tous les auteurs :
Taris N, Amand NDS, Hild C, Mathelin C, Chrétien M

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/42425871

Résumé

Male breast cancer (MBC) is rare, and its genetic basis remains poorly characterized. Over the past few decades, genetic screening strategies have evolved from analyses focusing solely on the BRCA1/2 genes to extensive multigene panels. Longitudinal data describing this transition in men remain scarce.